Table 1

Correlation between STS immunoreactivity and other parameters in human endometrial carcinoma

STS expressionP
+ (n = 65)− (n = 11)
ER LI (%)50.7 ± 13.752.1 ± 9.8N.S.
PR LI (%)41.9 ± 9.837.4 ± 13.9N.S.
Ki67 LI (%)31.0 ± 16.824.0 ± 12.8N.S.
Age (years)48.4 ± 7.644.1 ± 8.1N.S.
Grade 1323
Grade 2204
Grade 3134N.S.
Overall survival (5 years)87.5%87.5%N.S.
Disease-free survival (5 years)80.0%80.0%N.S.
  • NOTE. All data except for grade and survival are presented as mean ± 95% confidence interval.

  • Abbreviations: STS, steroid sulfatase; N.S., not significant; PR, progesterone receptor; ER, estrogen receptor.